CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: coccidiostat
Accession: CHEBI:35818
browse the term
Definition: An agent useful in the treatment or prevention of coccidiosis in man or animals.
Synonyms: related_synonym: anticoccidial agent; coccidiostats
G
Slc19a3
solute carrier family 19, member 3
multiple interactions
ISO
Amprolium inhibits the reaction [SLC19A3 protein results in increased uptake of Metformin]; Amprolium inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]
CTD
PMID:26528626
NCBI chr 1:82,990,242...83,016,541
Ensembl chr 1:82,990,244...83,016,169
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
decreases expression increases transport
ISO
antibiotic G 418 results in decreased expression of ABCB1 mRNA ABCB1 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcc1
ATP-binding cassette, sub-family C member 1
increases transport
ISO
ABCC1 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Abcc2
ATP-binding cassette, sub-family member 2
increases transport
ISO
ABCC2 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc3
ATP-binding cassette, sub-family C member 3
increases transport
ISO
ABCC3 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
G
Atm
ataxia telangiectasia mutated
increases expression
ISO
antibiotic G 418 results in increased expression of ATM protein mutant form
CTD
PMID:15498871
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Avpr2
arginine vasopressin receptor 2
multiple interactions
ISO
antibiotic G 418 results in increased expression of and results in increased activity of AVPR2 protein mutant form
CTD
PMID:12414899 PMID:14998935
NCBI chr X:72,935,371...72,938,034
Ensembl chr X:72,935,708...72,939,108
G
Capn2
calpain 2
increases cleavage
ISO
antibiotic G 418 results in increased cleavage of CAPN2 protein
CTD
PMID:15241557
NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
G
Casp12
caspase 12
increases cleavage
ISO
antibiotic G 418 results in increased cleavage of CASP12 protein
CTD
PMID:15241557
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp3
caspase 3
increases activity
ISO
antibiotic G 418 results in increased activity of CASP3 protein
CTD
PMID:15241557
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp9
caspase 9
increases activity multiple interactions
ISO
antibiotic G 418 results in increased activity of CASP9 protein benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [antibiotic G 418 results in increased activity of CASP9 protein]
CTD
PMID:15241557
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cftr
cystic fibrosis transmembrane conductance regulator
increases expression
ISO
antibiotic G 418 results in increased expression of CFTR protein mutant form
CTD
PMID:17541014
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
F7
coagulation factor VII
multiple interactions
ISO
antibiotic G 418 results in increased expression of and results in increased activity of F7 protein
CTD
PMID:16706976
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Gpx1
glutathione peroxidase 1
affects localization
ISO
antibiotic G 418 affects the localization of GPX1 mRNA mutant form
CTD
PMID:28743738
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Hsf1
heat shock factor 1
increases activity
ISO
antibiotic G 418 results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
increases expression
ISO
antibiotic G 418 results in increased expression of KCNJ1 protein mutant form
CTD
PMID:12911542
NCBI chr 9:32,283,714...32,310,493
Ensembl chr 9:32,283,789...32,310,493
G
Mmut
methylmalonyl-Coenzyme A mutase
affects expression multiple interactions
ISO
antibiotic G 418 affects the expression of MMUT mRNA mutant form [antibiotic G 418 co-treated with Gentamicins] affects the activity of MMUT protein mutant form; [antibiotic G 418 co-treated with Gentamicins] affects the expression of MMUT mRNA mutant form; antibiotic G 418 promotes the reaction [Gentamicins affects the expression of MMUT protein mutant form]
CTD
PMID:19427250
NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
G
Slc4a4
solute carrier family 4 (anion exchanger), member 4
increases expression
ISO
antibiotic G 418 results in increased expression of SLC4A4 protein mutant form
CTD
PMID:18614622
NCBI chr 5:88,941,717...89,387,515
Ensembl chr 5:89,034,345...89,387,512
G
Upf1
UPF1 RNA helicase and ATPase
affects localization
ISO
antibiotic G 418 affects the localization of UPF1 protein
CTD
PMID:28743738
NCBI chr 8:70,784,143...70,806,418
Ensembl chr 8:70,784,175...70,805,928
G
Actb
actin, beta
increases expression
ISO
Lasalocid results in increased expression of ACTB protein
CTD
PMID:37788135
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
G
Anxa1
annexin A1
increases expression
ISO
Lasalocid results in increased expression of ANXA1 protein
CTD
PMID:37788135
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Anxa2
annexin A2
increases expression
ISO
Lasalocid results in increased expression of ANXA2 protein
CTD
PMID:37788135
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Dsp
desmoplakin
increases expression
ISO
Lasalocid results in increased expression of DSP protein
CTD
PMID:37788135
NCBI chr13:38,335,357...38,382,553
Ensembl chr13:38,335,270...38,382,553
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
ISO
Lasalocid results in increased expression of HNRNPA1 protein
CTD
PMID:37788135
NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
increases expression
ISO
Lasalocid results in increased expression of HNRNPA2B1 protein
CTD
PMID:37788135
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
G
Hspb1
heat shock protein 1
increases expression
ISO
Lasalocid results in increased expression of HSPB1 protein
CTD
PMID:37788135
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Ivl
involucrin
increases expression
ISO
Lasalocid results in increased expression of IVL protein
CTD
PMID:37788135
NCBI chr 3:92,478,206...92,481,097
Ensembl chr 3:92,478,209...92,481,042
G
Jup
junction plakoglobin
increases expression
ISO
Lasalocid results in increased expression of JUP protein
CTD
PMID:37788135
NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589
G
Krt5
keratin 5
increases expression
ISO
Lasalocid results in increased expression of KRT5 protein
CTD
PMID:37788135
NCBI chr15:101,615,504...101,621,340
Ensembl chr15:101,615,505...101,621,333
G
Krt6a
keratin 6A
increases expression
ISO
Lasalocid results in increased expression of KRT6A protein
CTD
PMID:37788135
NCBI chr15:101,598,363...101,602,746
Ensembl chr15:101,598,345...101,602,742
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
Lasalocid results in decreased expression of MAPT protein
CTD
PMID:16930453
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Pkp1
plakophilin 1
increases expression
ISO
Lasalocid results in increased expression of PKP1 protein
CTD
PMID:37788135
NCBI chr 1:135,799,132...135,846,945
Ensembl chr 1:135,799,133...135,846,945
G
Ppl
periplakin
increases expression
ISO
Lasalocid results in increased expression of PPL protein
CTD
PMID:37788135
NCBI chr16:4,904,155...4,950,345
Ensembl chr16:4,904,155...4,950,285
G
S100a10
S100 calcium binding protein A10 (calpactin)
increases expression
ISO
Lasalocid results in increased expression of S100A10 protein
CTD
PMID:37788135
NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950
G
S100a11
S100 calcium binding protein A11
increases expression
ISO
Lasalocid results in increased expression of S100A11 protein
CTD
PMID:37788135
NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
G
S100a16
S100 calcium binding protein A16
increases expression
ISO
Lasalocid results in increased expression of S100A16 protein
CTD
PMID:37788135
NCBI chr 3:90,444,561...90,450,458
Ensembl chr 3:90,444,561...90,450,458
G
Serpinb2
serine (or cysteine) peptidase inhibitor, clade B, member 2
increases expression
ISO
Lasalocid results in increased expression of SERPINB2 protein
CTD
PMID:37788135
NCBI chr 1:107,439,153...107,453,330
Ensembl chr 1:107,439,153...107,463,208
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
Lasalocid results in increased expression of SPRR1A protein
CTD
PMID:37788135
NCBI chr 3:92,391,261...92,393,188
Ensembl chr 3:92,391,259...92,393,202
G
Sprr1b
small proline-rich protein 1B
increases expression
ISO
Lasalocid results in increased expression of SPRR1B protein
CTD
PMID:37788135
NCBI chr 3:92,344,115...92,346,124
Ensembl chr 3:92,344,116...92,346,096
G
Sprr2d
small proline-rich protein 2D
increases expression
ISO
Lasalocid results in increased expression of SPRR2D protein
CTD
PMID:37788135
NCBI chr 3:92,246,447...92,248,187
Ensembl chr 3:92,246,447...92,248,180
G
App
amyloid beta precursor protein
multiple interactions
EXP ISO
Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-40)]; Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-42)] Monensin inhibits the reaction [Ketamine results in decreased expression of and results in increased cleavage of APP protein]
CTD
PMID:35378374
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Atp7a
ATPase, copper transporting, alpha polypeptide
multiple interactions
ISO
Monensin inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]
CTD
PMID:17510416
NCBI chr X:105,070,830...105,171,766
Ensembl chr X:105,070,882...105,168,532
G
Bace1
beta-site APP cleaving enzyme 1
multiple interactions
ISO
Monensin inhibits the reaction [Ketamine results in increased expression of and affects the localization of BACE1 protein]
CTD
PMID:35378374
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
increases expression
ISO
Monensin results in increased expression of BNIP3 protein
CTD
PMID:30718715
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
Casp3
caspase 3
multiple interactions increases activity
ISO
Lithium inhibits the reaction [Monensin results in increased activity of CASP3 protein]
CTD
PMID:20799912
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
multiple interactions increases activity
ISO
Lithium inhibits the reaction [Monensin results in increased activity of CASP7 protein]
CTD
PMID:20799912
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
multiple interactions
ISO
Monensin inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Monensin inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]
CTD
PMID:18346843
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Egf
epidermal growth factor
multiple interactions
ISO
[EGF protein co-treated with Monensin] results in increased expression of MYC mRNA
CTD
PMID:12632255
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Il6
interleukin 6
decreases secretion
ISO
Monensin results in decreased secretion of IL6 protein
CTD
PMID:11216681
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ins1
insulin I
decreases degradation
ISO
Monensin results in decreased degradation of INS1 protein
CTD
PMID:2645939
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Myc
myelocytomatosis oncogene
multiple interactions
ISO
[EGF protein co-treated with Monensin] results in increased expression of MYC mRNA
CTD
PMID:12632255
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Parp1
poly (ADP-ribose) polymerase family, member 1
increases cleavage
ISO
Monensin results in increased cleavage of PARP1 protein
CTD
PMID:30718715
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Slc6a2
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
multiple interactions
ISO
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]]
CTD
PMID:29908239
NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
multiple interactions
ISO
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]]
CTD
PMID:29908239
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
multiple interactions
ISO
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A4 protein results in increased uptake of Serotonin]]
CTD
PMID:29908239
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
decreases expression increases expression multiple interactions
ISO
Monensin results in decreased expression of TRPM2 protein alternative form Monensin results in increased expression of TRPM2 protein alternative form Lithium inhibits the reaction [Monensin results in increased expression of TRPM2 protein alternative form]
CTD
PMID:20799912
NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
G
Zeb1
zinc finger E-box binding homeobox 1
increases response to substance
ISO
ZEB1 protein results in increased susceptibility to Monensin
CTD
PMID:30718715
NCBI chr18:5,591,330...5,775,468
Ensembl chr18:5,591,860...5,775,467
G
Angpt1
angiopoietin 1
decreases expression
ISO
Roxarsone results in decreased expression of ANGPT1 mRNA
CTD
PMID:18414637
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
G
Cnmd
chondromodulin
decreases expression
ISO
Roxarsone results in decreased expression of CNMD mRNA
CTD
PMID:18414637
NCBI chr14:79,875,126...79,899,596
Ensembl chr14:79,875,130...79,899,610
G
Cxcl9
C-X-C motif chemokine ligand 9
decreases expression
ISO
Roxarsone results in decreased expression of CXCL9 mRNA
CTD
PMID:18414637
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases secretion
ISO
Roxarsone results in increased secretion of ENPP2 protein
CTD
PMID:22952646
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
G
Fhdc1
FH2 domain containing 1
decreases expression
ISO
Roxarsone results in decreased expression of INF1 mRNA
CTD
PMID:18414637
NCBI chr 3:84,349,503...84,387,746
Ensembl chr 3:84,349,505...84,387,736
G
Hgf
hepatocyte growth factor
increases expression
ISO
Roxarsone results in increased expression of HGF mRNA
CTD
PMID:18414637
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Lep
leptin
decreases expression
ISO
Roxarsone results in decreased expression of LEP mRNA
CTD
PMID:18414637
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Mmp9
matrix metallopeptidase 9
increases expression
ISO
Roxarsone results in increased expression of MMP9 mRNA; Roxarsone results in increased expression of MMP9 protein
CTD
PMID:22952646
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mtor
mechanistic target of rapamycin kinase
increases expression multiple interactions
ISO
Roxarsone results in increased expression of MTOR mRNA Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein]
CTD
PMID:35985552
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Nos3
nitric oxide synthase 3, endothelial cell
multiple interactions
ISO
Roxarsone results in increased phosphorylation of and results in increased activity of NOS3 protein
CTD
PMID:18414637
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Pecam1
platelet/endothelial cell adhesion molecule 1
multiple interactions increases expression
EXP
Semaxinib inhibits the reaction [Roxarsone results in increased expression of PECAM1 protein]
CTD
PMID:30028964
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Plg
plasminogen
decreases expression
ISO
Roxarsone results in decreased expression of PLG mRNA
CTD
PMID:18414637
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Rps6kb1
ribosomal protein S6 kinase, polypeptide 1
multiple interactions increases expression
ISO
Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein] Roxarsone results in increased expression of RPS6KB1 mRNA
CTD
PMID:35985552
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Roxarsone results in increased expression of and results in increased secretion of VEGFA protein
CTD
PMID:24035937
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
increases hydroxylation
ISO
CYP2C8 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
increases hydroxylation
ISO
CYP2C9 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
decreases expression
ISO
Sulfadiazine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Hmbs
hydroxymethylbilane synthase
decreases activity
ISO
Sulfadiazine decreases activity of purified Hmbs protein
RGD
PMID:6893114
RGD:26923963
NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525
G
Il6
interleukin 6
multiple interactions
ISO
[Sulfadiazine co-treated with Pyrimethamine] results in decreased expression of IL6 protein; [Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein
CTD
PMID:10888991 PMID:37722575
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Lpo
lactoperoxidase
decreases expression
ISO
Sulfadiazine results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr11:87,697,254...87,716,750
Ensembl chr11:87,697,254...87,719,115
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
Sulfadiazine results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
increases acetylation
ISO
NAT2 protein results in increased acetylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Olig2
oligodendrocyte transcription factor 2
decreases expression
ISO
Sulfadiazine results in decreased expression of OLIG2 mRNA
CTD
PMID:34748853
NCBI chr16:91,016,745...91,025,567
Ensembl chr16:91,022,345...91,025,565
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Sulfadiazine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 7:143,531,819...143,979,780
Ensembl chr 7:143,555,665...143,978,231
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
decreases expression
ISO
Sulfadiazine results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all